Brief: Pharming Group Starts Phase II Trial For Leniolisib In PIDs

Pharming

10/10/2024 06:02

Oct 10 (Reuters) - Pharming Group NV  PHAR.AS :
    * STARTS PHASE II TRIAL FOR LENIOLISIB IN PIDS
    * TRIAL OPEN FOR ENROLLMENT INCLUDING ALPS-FAS, CTLA4,
NFKB1, PTEN
PATIENTS
    * PHASE II TRIAL TO INCLUDE APPROXIMATELY 12 PATIENTS

Source text for Eikon:  ID:nGNE5sb6dc 
Further company coverage:  PHAR.AS 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))